obesity drug news today glp-1 2025 sep 30 Market Size to Hit USD 66.57 Billion by 2035 New oral GLP-1 drug delivers

Description

Lund, P

Because of these broad effects, we wanted to see whether they would reduce all-cause mortality compared with another more weight-neutral diabetes medication. Mavromatis and colleagues conducted an observational study in which they used the Optum database to identify 170,030 adults (mean age, 56.8 years

If youre wondering whether your situation qualifies, heres what your lawyer will consider: Exposure history: Do your pharmacy records or EHR notes verify that you used a qualifying GLP-1 medication, that your dosage increased over time, and that your injury occurred within a plausible exposure window

Our guide on Washington Medicare & Medicaid Changes for 2026 covers how these programs interact and what changed this year for dual-eligible beneficiaries